The use of general anesthetics (GAs), such as isoflurane, ketamine, nitrous oxide and propofol, shows promise in treating depression and mood disorders, based on the results of a novel study.
Researchers noted major depressive disorder affects more than 300 million people globally and remains a leading risk factor for death by suicide.
According to the study, anesthetic drugs contain antidepressant properties that target glutamatergic and GABAergic neurotransmission. Glutamate, the primary